FdaApplication

NDA 216984

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSHORLA PHARMA LTD
application_typeNDA
approval_date2024-06-25

Products (2)

ProductActive ingredientStrengthDosage form
TEPYLUTETHIOTEPA100MG/10ML (10MG/ML)SOLUTION;INTRAVENOUS
TEPYLUTETHIOTEPA15MG/1.5ML (10MG/ML)SOLUTION;INTRAVENOUS

2 products